Abstract
Myocardial injury, represented by elevated cardiac enzymes, has been associated with increased morbidity and mortality in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infections. Coronavirus disease 2019 (COVID-19) has created unique challenges in approaching patients with acute ST-segment changes. We describe two distinct cases of ST elevation on electrocardiogram occurring in patients with COVID-19 and review important diagnostic and management considerations for the front-line clinician.
Cite
CITATION STYLE
Sang, C. J., Heindl, B., Von Mering, G., Brott, B., Kopf, R. S., & Rajapreyar, I. (2020). ST Elevations in the Era of COVID-19. Case Reports in Cardiology, 2020, 1–7. https://doi.org/10.1155/2020/8845627
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
